Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Robust Gold, Silver Projects & Promising Drill Results

(Click to play video.) Affinity Metals Corp. ( TSX-V: AFF , Forum ) is focused on the acquisition, exploration, and development of strategic metal deposits within North America. Affinity is following a hybrid approach of combining the advancement of stra...

Software For Safe Medical Cannabis Access

Alternate Health’s integrated health services features clinical laboratories and CanaPass - online patient management software for safe access to medical cannabis. Currently generating revenue, Alternate Health plans to reinvest profit...

SunPower's Energy Storage Reflecting Well on Its Shares

SunPower Corp. shares are trading 6% higher today as the firm announced that its Equinox Storage paired with its platform provides energy independence to residential users. Global sustainable energy company SunPower Corp. (SPWR:NASDAQ) today announced the introduc...

Disruptive Technology Poised to Deliver Significant Advancement in Bladder Cancer Detection

Chris Temple, editor and publisher of The National Investor, explains why he recommends this small-cap as a Buy. Imagin Medical's disruptive technology is poised to deliver the most significant advancement in bladder cancer detection and removal in decades , ma...

Two Analysts See Company as a Buy for 'Game-Changing' Potential in Bladder Cancer ...

Two Analysts See Company as a Buy for 'Game-Changing' Potential in Bladder Cancer Detection and Surgery The disruptive technology is 'poised to deliver significant advancement in bladder cancer detection.' Imagin Medical Inc. (IME:CSE; ...

XPhyto: Is Mescaline the Next Big Mood-Modifying Medicine?

It has the potential to be the next frontier in the psychedelics renaissance, and it represents an unprecedented opportunity to innovate a notable advancement in mental health therapy. In anecdotal studies, mescaline has shown promise in treating depression, anxiety, PTSD,...

Small-Cap's Large Solar Project in Puerto Rico Moves Closer to Fruition

The support of the Puerto Rico Financial Oversight and Management Board advances the solar project. Greenbriar Capital Corp.'s (GRB:TSX.V; GEBRF:OTC) Montalva 100- to 165-megawatt solar project took several steps forward when in August the company reported that the P...

Platinum Group Metals' Shares Trade Up 35% on Waterberg Mine Prospects and Soaring PGM Demand

After opening flat today, shares of Platinum Group Metals Ltd. climbed to a new 52-week high price fueled by high demand and increases in platinum group metals prices. The firm claims its primary objective is now the advancement of the palladium dominant Waterberg Project in S...

Novavax Announces Its First-in-Human Coronavirus Vaccine Trial Will Begin in Mid-May

Shares of Novavax traded 20% higher setting a new 52-week high price after the company reported that it has accelerated initiation of a Phase 1 clinical trial for its coronavirus vaccine candidate NVX-CoV2373. The study will commence in mid-May with preliminary results expec...

Surface Oncology Shares Trade Up 40% on Phase1 Study Plans for SRF617 Combined with Merck's KEYTRUDA

Shares of Surface Oncology set a new 52-week high price after the company reported that it is partnering with Merck & Co. in an immuno-oncology study of SRF617, targeting CD39 in combination with KEYTRUDA® (pembrolizumab) in solid tumor patients. Clinical-...
1 2 3 4 5 6 7 8 9 10 ...